Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial membrane thiol-rich proteins represent a collective group of essential proteins located within the cytoplasmic membrane and cell wall of bacteria and fungi that are characterized by a high density of cysteine residues. These proteins play critical roles in vital microbial processes, including cellular respiration (via the electron transport chain), active transport of nutrients, and the maintenance of redox homeostasis. Because the thiol (sulfhydryl) groups in these proteins are highly nucleophilic, they serve as the primary molecular targets for silver-based antimicrobials and other heavy metal biocides. When silver ions interact with these targets, they form stable S-Ag bonds that cause the proteins to denature and lose their functional conformation. This interaction leads to the immediate inactivation of membrane-bound enzymes like NADH dehydrogenase, resulting in the collapse of the proton motive force and the cessation of ATP production. Furthermore, the disruption of these proteins compromises the integrity of the microbial membrane, leading to the leakage of essential ions such as potassium and the generation of lethal levels of reactive oxygen species (ROS). This multi-target mechanism of action is a key reason why silver remains an effective broad-spectrum antimicrobial with a low propensity for the development of high-level resistance.
Silver ions (Ag+) or heavy metal cations bind with high affinity to the thiol (-SH) groups of these proteins, leading to protein denaturation, inactivation of essential enzymes (such as NADH dehydrogenase), disruption of the electron transport chain, and increased membrane permeability.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial membrane thiol-rich proteins.